China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
NEW YORK, Feb. 28, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Pearson plc (NYSE:PSO) American Depositary Receipts between January 21, 2016 and January 17, 2017.
Click here to learn about the case: http://www.wongesq.com/pslra/pearson-plc. There is no cost or obligation to you.
According to the complaint, throughout the class period, the Company made materially false and/or misleading statements regarding the Company’s business, operational and compliance policies. In particular, the complaint alleges the Company made overly optimistic projections for 2017 and 2018 regarding its U.S. education business when, in reality, students were not likely to purchase the Company’s products when more affordable alternatives were available.
On January 18, 2017, Pearson issued a press release announcing that it no longer expected to achieve its operative profit guidance for 2018 as a result of “[t]he North American higher education courseware market being much weaker than expected” and that Pearson would “rebase” its dividend “from 2017 onwards.” Following this news, shares of Pearson fell approximately 29% on January 18, 2017, from a previous close of $9.99 to a close of $7.13 per share.
If you suffered a loss in Pearson you have until April 25, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/pearson-plc.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
